|
Jun 15
|
AstraZeneca’s ENHERTU Enters Pivotal Phase 3 Trial for Endometrial Cancer
|
|
Jun 13
|
Sector Update: Health Care Stocks Softer Friday Afternoon
|
|
Jun 13
|
AstraZeneca taps Chinese biotech in $5.2bn chronic disease research deal
|
|
Jun 13
|
AstraZeneca forms an AI deal in China; Third Harmonic advances liquidation plans
|
|
Jun 13
|
AstraZeneca Enters Deal With CSPC Pharma Valued at Up to $5.33 Billion
|
|
Jun 13
|
The Zacks Analyst Blog Highlights Microsoft, AstraZeneca and BlackRock, Taylor Devices and Geospace Technologies
|
|
Jun 13
|
AstraZeneca signs AI research deal with China's CSPC for chronic diseases
|
|
Jun 12
|
Top Stock Reports for Microsoft, AstraZeneca & BlackRock
|
|
Jun 11
|
Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel
|
|
Jun 10
|
Astrazeneca (AZN) Outpaces Stock Market Gains: What You Should Know
|
|
Jun 10
|
AstraZeneca (LSE:AZN) Partners In Quantum Leap For Drug Development Efficiency
|
|
Jun 10
|
Merck Secures FDA Nod for New RSV Antibody Enflonsia in Infants
|
|
Jun 10
|
RFK Jr. removes CDC vaccine panel members: What to know
|
|
Jun 9
|
Innovation Fuels Rally for Tempus AI: Should You Buy the Stock Today?
|
|
Jun 9
|
AstraZeneca and Pangaea partner for AI detection of hypophosphatasia
|
|
Jun 9
|
Merck Pill Lowers Cholesterol Levels. By How Much Is the Critical Point.
|
|
Jun 9
|
Beyfortus Output Tripled As Sanofi, AstraZeneca Scale Up For RSV Season
|
|
Jun 9
|
IonQ To Buy Oxford Ionics In $1 Billion Deal As Acquisition Spree Continues
|
|
Jun 9
|
EC approves AstraZeneca’s acalabrutinib combo for CLL
|
|
May 27
|
AstraZeneca (LSE:AZN) Gains EU Recommendation For Imfinzi in Bladder Cancer Treatment
|